British contract research organisation (CRO) ClinTec International plans to bolster its existing presence in the Middle East and North Africa with a new office in Istanbul.
The company, which already has bases in the region in Cairo, Egypt, Dubai Health Care City, UAE, and Beirut and Lebanon, said its Turkey office would give its global team access to a new patient population.
Founder and CEO Dr Rabinder Buttar said: “The launch of this new office … reflects the growing significance of Turkey- and the wider MENA region- to the global clinical research market
“We are delighted to be at the forefront of developing expertise in Turkey and the MENA region as a whole.”
Established in 1997, ClinTec has had a presence in Africa for over five years and the Middle East for over seven years, and last year commenced operations in Malawi in a move that strengthened its presence in vaccine development.